Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

86 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Completed

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

NCT01217437

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 158 locations
View Trial Details
Completed

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

NCT02955069

Conditions
Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Centers SC-2 Denver, Colorado, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 35 locations
View Trial Details
Completed

Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma

NCT00883688

Conditions
Brain Cancer, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

NCT02402062

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Institut Catalá d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Provincial de Castellón Castellon, Valencia, Spain
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
View Trial Details

Related conditions